Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization
Recruiting · NCT03622983 · Observational (researchers observe without assigning treatment) · Lead sponsor: Centre Hospitalier Intercommunal Creteil
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The management of pelvic gynecological cancers (PGC) is based on the determination of extension to guide treatments. The biology of the CGP is constantly evolving and personalized medicine adapted to this biology is currently in full development. For example, sequencing ovarian tumors can select patients who can benefit from anti-PARP therapy. There is therefore a need for patients to have biological samples of their tumor. Various studies on ovarian, endometrial and cervical cancer have sought to identify the factors predictive of recurrence of these cancers. The results obtained are very promising. This study will permit to collect biological samples and detailed clinical data that would allow to test hypotheses and develop a personalized medicine based on clinical and biological characteristics of patients.
Who can take part
Inclusion criteria
- Diagnosis of pelvic gynecological cancer posed on initial histological analysis or during recurrence;
- Or diagnosis of endometriosis on histology or imaging
- Age ≥ 18 years;
- Affiliation to the general social security scheme;
- Consent signed.
Exclusion criteria
- Refusal of the patient;
- Non-affiliation to the general social security scheme.
Where it is running
2 locations listed.
- CHI Creteil - Créteil, France
- CHU Tenon - Paris, France